perindopril has been researched along with Proteinuria in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 17 (77.27) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco, P; Bugeja, A; Clark, EG; Sood, MM | 1 |
| Amann, K; Boor, P; Heidland, A; Lill, M; Sebeková, K | 1 |
| Dijoud, F; Egan, EJ; Gilibert, S; Sassard, J | 1 |
| Beckett, N; Bulpitt, C; Burch, L; Fagard, R; Fletcher, A; Li, M; Narkiewicz, K; Nitsch, D; Peters, R; Poulter, R; Wang, N | 1 |
| Bertram, D; Blanc-Brunat, N; Lo, M; Sassard, J | 1 |
| Cordonnier, DJ; Cox, AJ; Gilbert, RE; Holthöfer, H; Kelly, DJ; Langham, RG; Pinel, N; Thomson, NM; Zaoui, P | 1 |
| Amemiya, M; Ando, Y; Asano, Y; Honma, S; Iimura, O; Kusano, E; Muto, S; Tanba, K; Yanagiba, S | 1 |
| Alexopoulos, E | 1 |
| Hayashi, K; Homma, K; Kanda, T; Matsuda, H; Saruta, T; Takamatsu, I; Tatematsu, S; Wakino, S; Yoshioka, K | 1 |
| Belair, MF; Chainey, A; Chevalier, J; Mandet, C; Michel, O; Myara, I; Plante, GE; Renaud, IM | 1 |
| Lo, M; Naelten, G; Trigo, LF | 1 |
| Brezniceanu, ML; Chan, JS; Filep, JG; Guo, DF; Hamet, P; Hsieh, TJ; Ingelfinger, JR; Liu, F; Liu, Q; Sachetelli, S; Sigmund, CD; Zhang, SL | 1 |
| Cohen, R; Emonnot, L; Lo, M | 1 |
| Overlack, A; Stumpe, KO | 1 |
| Alivanis, P; Dioudis, C; Goutsaridis, N; Grekas, D; Kalevrosoglou, I; Papoulidou, F; Tourkantonis, A | 1 |
| el-Shahawy, M; Khwaja, S; Massry, SG; Nosrati, SM | 1 |
| Ha, SK; Ho Shin, J; Hun Kim, D; Jung Kim, S; Rae Kim, K; Su Park, H; Suk Han, D; Yong Lee, S; Yung Lee, H | 1 |
| Hurst, M; Jarvis, B | 1 |
| Lee, YJ; Tsai, JC | 1 |
| Bilous, RW; Cordonnier, DJ; Pinel, N; White, KE | 1 |
| Beyer, J; Bockisch, A; Frank, M; Kopf, D; Lehnert, H; Schmitz, H | 1 |
| Aaltonen, P; Cox, AJ; Gilbert, RE; Holthöfer, H; Jerums, G; Kelly, DJ; Langham, R; Panagiotopoulos, S; Rumble, JR | 1 |
1 review(s) available for perindopril and Proteinuria
| Article | Year |
|---|---|
Perindopril: an updated review of its use in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Drug Therapy, Combination; Fibrinolysis; Hemodynamics; Humans; Hypertension; Perindopril; Proteinuria | 2001 |
7 trial(s) available for perindopril and Proteinuria
| Article | Year |
|---|---|
Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial.
Topics: Age Factors; Aged, 80 and over; Aging; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Indapamide; Kidney; Kidney Diseases; Male; Perindopril; Proportional Hazards Models; Proteinuria; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2013 |
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biopsy; Blood Pressure; Creatinine; Diabetic Nephropathies; Gene Expression Regulation; Glycated Hemoglobin; Humans; In Situ Hybridization; Membrane Proteins; Perindopril; Placebos; Proteins; Proteinuria | 2002 |
Differing anti-proteinuric action of candesartan and losartan in chronic renal disease.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Female; Humans; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Nitric Oxide; Perindopril; Proteinuria; Tetrazoles | 2003 |
A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS).
Topics: Adult; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Indoles; Kidney Diseases; Male; Middle Aged; Perindopril; Proteinuria; Treatment Outcome | 1993 |
Effect of angiotensin converting enzyme inhibition by perindopril on proteinuria of primary renal diseases.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Female; Humans; Indoles; Kidney Diseases; Male; Middle Aged; Perindopril; Proteinuria; Serum Albumin; Sodium; Treatment Outcome | 1997 |
Does ACE inhibition slow progression of glomerulopathy in patients with Type 2 diabetes mellitus?
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Kidney Glomerulus; Microscopy, Electron; Middle Aged; Perindopril; Placebos; Proteinuria | 2001 |
A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Creatinine; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Nitrendipine; Perindopril; Proteinuria; Technetium Tc 99m Pentetate | 2001 |
14 other study(ies) available for perindopril and Proteinuria
| Article | Year |
|---|---|
Sickle cell disease: a case report of renal amyloidosis.
Topics: Adult; Amyloidosis; Anemia, Sickle Cell; Angiotensin-Converting Enzyme Inhibitors; Antibodies; DNA; Female; Humans; Hydroxyurea; Nephrotic Syndrome; Perindopril; Proteinuria; Serum Amyloid A Protein | 2018 |
Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Diabetic Nephropathies; Kidney Function Tests; Kidney Glomerulus; Male; Organ Size; Oxidative Stress; Perindopril; Proteinuria; Random Allocation; Rats; Rats, Zucker; Tetrazoles | 2009 |
Renoprotection persists after cessation of treatment with very low doses of perindopril in Lyon hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Kidney; Kidney Diseases; Kidney Function Tests; Male; Perindopril; Proteinuria; Rats | 2008 |
Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diuresis; Glomerulosclerosis, Focal Segmental; Hypertension, Renal; Kidney; Kidney Diseases; Losartan; Male; Natriuresis; Perindopril; Proteinuria; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2002 |
[Additive antiproteinuric effect of angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis].
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Chronic Disease; Collagen Type IV; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Male; Perindopril; Proteinuria; Tetrazoles; Treatment Outcome | 2003 |
Treatment of primary IgA nephropathy.
Topics: Adult; Antihypertensive Agents; Creatinine; Disease-Free Survival; Fish Oils; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Perindopril; Proteinuria | 2004 |
Long-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin-converting enzyme inhibitor/diuretic combination.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diuretics; Drug Combinations; Fibrosis; Indapamide; Kidney Function Tests; Male; Metabolic Clearance Rate; Obesity; Perindopril; Proteinuria; Rats; Rats, Zucker; Renal Insufficiency | 2004 |
Blood pressure and proteinuria after cessation of a brief renin-angiotensin system blockade in young and adult Lyon hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Losartan; Male; Perindopril; Proteinuria; Rats; Renin-Angiotensin System; Time Factors | 2005 |
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Blotting, Western; DNA, Complementary; Female; Gene Expression Regulation; Hypertension; Immunohistochemistry; Kidney; Kidney Diseases; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Perindopril; Proteins; Proteinuria; Rats; Renin-Angiotensin System | 2006 |
Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Hyperlipidemias; Hypertension; Kidney Diseases; Male; Perindopril; Proteinuria; Rats; Renin-Angiotensin System | 2008 |
Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Creatinine; Delayed-Action Preparations; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Indoles; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Nifedipine; Perindopril; Prospective Studies; Proteinuria; Sodium | 1995 |
ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Diabetes Mellitus, Type 2; Drug Resistance; Genotype; Humans; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Polymorphism, Genetic; Proteinuria | 2000 |
Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Comorbidity; Cough; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Prevalence; Proteinuria; Receptor, Bradykinin B2; Receptors, Bradykinin; Sex Distribution; Taiwan | 2001 |
Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Base Sequence; Diabetes Mellitus, Experimental; Diabetic Nephropathies; DNA Primers; Guanidines; In Situ Hybridization; Male; Membrane Proteins; Mutation; Perindopril; Proteins; Proteinuria; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2002 |